Table 2.
Relationship between stromal FAP expression and clinicopathological factors
| Characteristics | FAP negative/weak | FAP moderate/strong | P value |
|---|---|---|---|
| Age | 0.911 | ||
| ≥65 | 16 | 26 | |
| <65 | 3 | 3 | |
| T categorya | 0.479 | ||
| T1/T2 | 5 | 4 | |
| T3/T4 | 14 | 25 | |
| N categorya | 0.444 | ||
| N0 | 10 | 12 | |
| N1 | 9 | 17 | |
| M categorya | 0.317 | ||
| M0 | 17 | 22 | |
| M1 | 2 | 7 | |
| UICCb stage | 0.406 | ||
| I/II | 11 | 13 | |
| III/IV | 8 | 16 | |
| Histological differentiation | <0.05 | ||
| Well | 6 | 2 | |
| Moderate/Poor | 13 | 27 |
aTNM classification of the UICC, bUICC, Union for International Cancer Control